摘要
Objective: To reveal the anti-inflammatory mechanism of Guanxin Ⅴ, which is prescribed for ventricular remodeling in clinical practice. Methods: Guanxin Ⅴ-, ventricular remodeling-, and inflammationrelated targets were obtained through an integrated strategy of virtual screening and systematic pharmacology, and then the shared targets were visualised with a Venn diagram. Guanxin Ⅴ network and the protein-protein interaction network were drawn, and enrichment analysis was conducted. Finally, the main results obtained from the integrated strategy were validated by molecular docking and in vivo experiments. Results: A total of 251, 11,425, and 15,246 Guanxin Ⅴ-, ventricular remodeling-, and inflammation-related targets were acquired, respectively. Then, 211 shared targets were considered to contribute to the mechanism of ventricular remodeling treated by Guanxin Ⅴ. Guanxin network and the protein-protein interaction network were drawn, and enrichment analysis showed some cardiovascular-related biological processes and signaling pathways. Molecular docking revealed that the Guanxin Ⅴ-derived compounds could align with key targets. Final in vivo experiments proved that Guanxin Ⅴ reverses ventricular remodeling by inhibiting inflammation. Conclusion: Guanxin Ⅴ relieves ventricular remodeling by regulating inflammation, which provides new ideas for the anti-ventricular remodeling mechanism of Guanxin Ⅴ.
- 单位